Radiotherapy and Oncology

Article	Citations
Contents	154
Call For Papers: Radiotherapy & Oncology and The Lancet Oncology collaboration	121
529 Current standard of care treatment in non-metastatic cervix cancer	111
44 Ultrahypofractionated Versus Moderately Hypofractionated and Conventionally Fractionated Pelvic Radiotherapy for Prostate Cancer: Outcomes from 3 Prospective Clinical Trials	93
80 Stereotactic Body Radiation Therapy for Intrahepatic Graft Recurrence of Hepatocellular Carcinoma After Liver Transplantation	93
292 Correlation of cf DNA with response in head & neck cancer treated with definitive chemoradiotherapy	84
Response to the commentary on “Optimizing fractionation schedules for de-escalation radiotherapy in head and neck cancers using deep reinforcement learning” by Mohammad Zahid, and Heiko Enderling	81
23 Stereotactic Body Versus Conventional Fractionation External Beam Radiotherapy (EBRT) Boost for High-Risk Prostate Cancer (HR-PC); Early Results of PBS: A Phase II Randomized Trial (NCT03380806)	75
122 Effect of Different Treatment Planning Optimizers on Stereotactic Ablation Radiotherapy (SABR) Volumetric Modulated ARC Therapy (VMAT) Plans	75
31 Program Director Perspectives on the Implementation and Experiences of the Competence By Design Curriculum in Canadian Radiation Oncology Training Programs	73
525 Proton and carbon therapy: recent technological advances	71
33 An investigator-initiated clinical study using SBRT as “in situ vaccination”:‘R-ISV-FOLactis’trial	70
45 Stereotactic radiosurgery for tremor: a center experience.	69
54 Scattered Radiation to the Testis and Testosterone Secretion in Prostate Cancer Treated with Radiotherapy Alone	67
Corrigendum to “Parallel explorations in LA-NSCLC: Chemoradiation dose-response optimisation considering immunotherapy and cardiac toxicity sparing” [Radiother. Oncol. 200 (2024) 110477]	65
207 ctDNA-based WES enhances actionable alterations detection in locally advanced head and neck cancer	63
157 Adaptive radiation therapy	62
480 Addressing the education and training needs of RTT in particle radiation therapy	61
937: Prediction of the dose-averaged proton linear energy transfer using convolutional neural networks	58
3007: SABR prior to liver transplantation in HCC patients: a 10 years’ experience	55
2076: RapidBrachyIVBT: A dosimetry software for personalized image-guided intravascular brachytherapy	55
3050: Impact of a philanthropic online course about cervical cancer on the learning outcome	54
158: Validation of intrafraction prostate drift corrections on a 1.5T MR-linac using cine-MRI	53
2030: Impact & usability of virtual reality on emotional wellbeing of sarcoma patients:VR-SARC study	52
1086: Urethra-sparing single-dose ablative prostate radiotherapy with real-time motion management	51

3429: Modulating innate immunity by DNA damage response inhibition	50
1583: Phantom-based optimization of virtual monoenergetic image reconstruction in dual-energy CT	50
1232: Modern era radical radiotherapy toxicity: a preliminary CONCORDE analysis of the calibration arm	49
749: Reinforcement learning for accelerated automatic treatment planning optimization	49
204: PET-CT DenseNet outperforms advanced DL models for outcome prediction of oropharyngeal cancer	48
1062: Micro-dissected tumour tissues-on-chip; a tool for translational radiation oncology	48
2975: UHRT in PCa: a clinical and toxicity impact analysis from real world experience.	48
1635: In vivo dosimetry - keeping my finger on the pulse	47
687: Hearing loss after cranial radiation in children: a dosimetry study from the French registry PediaRT	45
1861: Performance of a heart substructures autocontouring tool after clinical implementation	45
2486: Impact of patient specific deep learning OAR segmentation on accumulated online adapted MRgRT dose	45
3201: Dosimetric properties of flexible 3D-printed boluses	44
1933: High-resolution Diode array vs film for QA of trigeminal neuralgia treatments with Cyberknife	44
941: Should Varian HyperArc make us re-think how we use conventional linacs for SRS?	43
2607: Carbon footprint reduction with the adoption of hypofractionation in a public health facility	43
2311: Treatment plan robustness in IMPT for esophageal cancer: every millimeter counts.	42
1962: Study protocol B-REST: respiratory und relaxation training in adjuvant radiotherapy of breast cancer	42
1432: Comparative study of various homogeneity indices in SIB-VMAT planning for head and neck tumors.	41
1487: Radiotherapy access in the Asia-Pacific: Are we making progress for low- & middle-income countries?	41
1586: Dose perturbation due to surgical clips and titanium mesh in proton therapy	41
285: Metal artifact in MR-based synthetic CT for intracranial radiotherapy: impact on dosimetry and setup	40
1977: PSMA-PET and PCa: an ancillary RADIOSA study beyond a numerical definition of oligometastatic state	40
760: Dependence on the calibration field in treatment verifications using the 1600SRS liquid array	40
1006: Prediction of cisplatin tolerance during chemoradiation in older HNSCC patients: A multicenter study	39
154: Identifying the Continuous Professional Development Educational Needs of Belgian RTTs	39
2116: Outcomes of EBRT and brachytherapy in anal cancer: retrospective analysis between 2016 and 2021	39
452: Can 1 mm PTV margin be used for radiosurgery patients laying on wedges?	39
2925: Urethral dosimetric implications of a multifocal MRI-based microboost in prostate robotic SBRT	39
2010: Postmastectomy radiotherapy after immediate breast reconstruction: toxicities and control rate.	38
3006: Clinical markers of altered Body image in Patients with Head and Neck cancers	38
2124: Respiratory gated planning of non-small cell lung cancer with new data-driven gated (DDG) PET/CT	37
2749: Feasibility of SBRT with CK in the scenario of lung metastases re-RT: monoinstitutional experience.	36
3194: LA-NSCLC: clinical outcomes and comparison of 2-weekly versus 4-weekly durvalumab consolidation	36
691: A single-arm confirmatory trial of IMRT alone for early-stage oropharyngeal cancer: JCOG1208	36
1537: Brachytherapy efficacy and safety in the treatment of primitive tongue carcinomas	36
1517: Intramedullary and leptomeningeal-epidural metastases. Outcomes of a rare and ominous condition.	36
2026: Quantitative T1 mapping in the presence of an implantable cardiac device on a 1.5T MR-linac	36
2353: X-irradiation, but not proton, irradiation, induces an inflammatory cytokine response in saliva	35
1136: Electron beam radiotherapy for the management of perianal malignancies	34
3346: How to balance the patient and clinician needs: Are we on the same side?	34
1651: The impact of ground-glass opacities on dose calculation accuracy for lung SBRT	33
3484: RAPTOR project: Verification	33
2974: Generalised Competing Risk models predict relative risk of cancer events in p16+ oropharynx cancer	32
2874: Interstitial brachytherapy in carcinoma cervix: long term results, toxicity and patterns of failure	32
512: Proton minibeam radiation therapy: elucidating in vivo mechanisms with infrared microspectroscopy	32
1247: ANTI-TUMOR AND ACUTE TOXICITY OF FRACTIONATED STEREOTACTIC RADIOTHERAPY COMBINED WITH HYPERTHERMIA	32
1317: Identifying Lymphocyte Infiltration for Rectal Cancer Outcome Prediction Using Phase III Trial Data	32
742: EXTREME HYPOFRACTIONATED RT FOR PROSTATE CA. Phase II. Results in toxicity and economical cost	32
3548: Virtual patients for clinical trials	31
2019: The Impact of Concurrent Chemotherapy on Stage II Nasopharyngeal Carcinoma	31

3379: Management of older patients with skin cancer: Are we overtreating?	31
1293: Immunotherapy-related hypothyroidism on head and neck cancer: impact of RT dose to the thyroid gland	31
972: Proton therapy for patients with meningioma—Long-term outcomes from ProReg and KiProReg study	31
2011: Physical & psychosocial effects of radical chemoradiotherapy for cervix cancer: a systematic review	30
692: T1 & T2 mapping on a Unity MRL in a clinically feasible timeframe	30
2578: Respiratory gating with CPAP in left breast cancer RT: preliminary results of a prospective study	30
910: Comparison of Eclipse and RayStation in Multi-Criteria Optimization in Prostate Cancer Radiotherapy	30
1622: Title: Gamma Knife Radiosurgery for Trigeminal Neuralgia: A review of 59 patients	30
2605: HDR brachytherapy boost plus EBRT in unfavorable prostate cancer: results in more then 700 patients	30
994: Terminology, Recording, Reporting for Ultra-High Dose Rates: ESTRO Physics of FLASH Workshop update	30
895: Predicting Overall Survival for Patients Who Underwent Adjuvant Chemoradiotherapy for Gastric Cancer	29
1839: Stimulation of immune response to overcome radioresistance in BRCA1 mutant breast cancer cells	29
A patient-specific auto-planning method for MRI-guided adaptive radiotherapy in prostate cancer	29
2489: Endothelial senescence primes aggressiveness of glioblastoma cells after radiotherapy	29
Validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic body radiation	29
1664: Assessing overall and fractional CTV coverage in breast cancer radiotherapy based on daily imaging	29
360: The role of SGRT in detecting inter and intra fraction errors in SBRT treatments to the lung	29
527: A novel integrated measure of cervical HDR brachytherapy plan quality	29
262: Radiation induces Mitochondrial Biogenesis and Cellular Quiescence Exit in PDOX models of pHGG	28
2889: Risk Assessment of Patient-Specific Quality Assurance Methods for Particle Therapy	28
1670: Facing the climate change: is radiotherapy as green as we would? A preliminary analysis	28
394: Dosimetric evaluation of synthetic 3DCTs reconstructed from a single x-ray radiograph using CNN	28
3043: Early response assessment of Ca cervix treated with PETCT based SIB-Online Adaptive Radiotherapy	28
12 Safety and Efficacy of Stereotactic Body Radiotherapy for Ultra-Central Thoracic Tumours	27
OC-0932 Preoperative radiation therapy in early breast cancer: phase II ROCK trial (NCT03520894)	27
304 the Changing Landscape of Radiation Therapy: Implications for Future Planning	27
SP-0510 Physicist: Integration of imaging modalities in treatment planning	27
Salvage thoracic reirradiation for recurrent non-small cell lung cancer: Clinical efficacy and the impact of consolidative immunotherapy	27
SP-1017 What have we learnt and translation to the clinic?	27
PO-1708 Application of dose accumulation for PTV margin design in MR-guided adaptive prostate SBRT	26
PO-1724 Dose-averaged LET may not be the best RBE-descriptor for proton therapy	26
MO-0384 A CT-radiomics model to predict recurrence post curative-intent radiotherapy for stage I-III NSCLC	26
OC-0592 Impact of palliative care referral on distress in patients undergoing RT for HNSCC: Randomized Trial	26
SP-0524 Prophylactic cranial irradiation in lung cancer: Where are we?	26
OC-0594 Head and Neck Squamous Cell Carcinoma derived CAFs alter their phenotype after ionizing radation	26
OC-0109 External validation of a prediction model for two-year mortality in esophageal cancer cohorts	26
SP-1007 For the motion	26
PO-1421 Is it possible to deliver on-line MR-guided RT for prostate cancer within a feasible time frame?	25
PO-1061 Acces to radiation therapy in Lebanon: current status and challenges	25
PO-1053 cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer	25
PO-1533 Determination of field output correction factors for the IBA Razor Diode	25
SP-0197 Status of brachytherapy education for brachytherapists and future needs in North America	25
PO-1468 LATTICE radiotherapy: A one institution experience	25
OC-0603 PEACE V – STORM randomized phase II trial for oligorecurrent nodal prostate cancer: acute toxicity	25
OC-0111 Prognostic factors for isolated local recurrence after resection of pancreatic ductal adenocarcinoma	25
PO-1423 PSA dynamics forecasts identify tumor recurrence after external radiotherapy for prostate cancer	25
PO-1779 Detection of mandibular osteoradionecrosis using novel imaging biomarkers for head and neck cancer	25
SP-0371 Every physicist should also be a fully skilled data scientist	24
PD-0733 Parameters influencing inter-Institute variability in KB plan prediction models for whole breast RT	24
SP-0013 Weekly contouring rounds and education movies to improve organ at risk delineation in neuro-oncology	24
PO-1685 Creating clinically competitive FLASH proton therapy treatment plans	24
OC-0426 ALDH genes as regulators of prostate cancer radioresistance, stemness and bone metastases	24
PO-1873 Is auto-segmentation in prostate radiotherapy efficient and accurate?	24
OC-0432 Patterns of failure in oral cavity squamous cell carcinoma treated with adjuvant radiotherapy	24
OC-0623 First-in-human clinical translation of oxygen-enhanced MRI onto an MR Linac	24
PD-0654 Surface Guided Radiotherapy accuracy vs tattoos position in 5- fractions breast radiotherapy.	24
OC-0088 Reduced tube feeding dependence by continuous improvements in head and neck radiotherapy	24
PO-1674 Going from planar kV-MV to kV-kV setup images in image-guided radiotherapy of breast cancer	24
PD-0230 Correlation between External and Internal Tumour Motion in Lung Stereotactic Ablative Radiotherapy	24
PO-1796 Dosimetric comparison of rectal dose reduction methods in brachytherapy for cervical cancer	23
109: Prostate Cancer-Specific Death Rates in Localized Prostate Cancer: Data from Two Randomized Trials	23
MO-0721 Clinicogenomic predictors for the pattern of failure in high-grade glioma	23
PO-1488 Local recurrence of prostate cancer after curative RT: the role of salvage SBRT re-irradiation	23
PO-1325 Automated rectal tumor segmentation with inter-observer variability-based uncertainty estimates	23
PO-1251 Perceived-health status in lung cancer survivors presenting long-term radiotherapy-related fatigue.	23
174: Influence of Palliative Radiotherapy on Toxicity and Survival in Patients Treated with Radium-223 Dichloride for Metastatic Castrate-Resistant Prostate Cancer	23
PO-1601 GPU accelerated Monte Carlo activation calculations for PET range verification in proton therapy	23
OC-0441 Risk of cardiac death increases with dose to cardiac sub structure avoidance region in lung cancer	23
PO-1835 A glimpse at breast internal mammary chain radiotherapy practice in the United Kingdom	23
MO-0804 Determinants of fatigue and longitudinal changes up to 2 years post-radiotherapy for breast cancer	23
PO-1652 A new machine learning-based clinical tool for vertebral level verification and treatment planning	23
Corrigendum to “DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1α, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma p	23
PD-0231 Acute toxicity after the 5-fraction versus 15-fraction radiotherapy regimen for early breast cancer	22
SP-0035 From atlas-based knowledge to ML-based planning solutions	22
PO-1886 Respiratory motion prediction based on LSTM and linear regression models	22
OC-0766 Gain from respiratory gating in left-sided partial breast irradiation in the DBCG PBI trial	22
Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer	22
MO-0789 Patient experience of head and neck treatment on a 1.5T MRLinac: is our adaptive solution tolerable?	22
OC-0775 Comprehensive proton dose prediction with Bayesian LSTMs	22
73: Erectile Function After 60 GY in 20 Fractions External Beam Radiotherapy to the Prostate	22

PO-1640 MRI-based deep learning autocontouring: Evaluation and implementation for brain radiotherapy	21
PO-1406 Re-irradiation in locally recurrent rectal cancer: a national survey of the AIRO GI study group	21
PO-1632 deep learning-based automatic segmentation of rectal tumors in endoscopy images	21
67: Ensuring Superior Reporting of Non-Inferiority Radiotherapy Clinical Trials: A Systematic Review	21
PO-1893 Gated dynamic trajectory radiotherapy: feasibility, mechanical accuracy and dosimetric validation	21
PO-2353 Impact of Breast volume on Skin toxicities during Hypo-fractionated Radiotherapy in Breast cancer	21
PO-1589 Clinical outcomes of two radiotherapy schedules for spinal cord compression	21
PO-1542 Seminal vesicle displacement with Hydrogel spacer insertion on prostate radiotherapy	21
PO-1914 Surface Guided Helical Tomotherapy for Total Marrow Irradiation	21
PO-1938 Organ motion in thorax and abdomen during radiotherapy: a multicenter study in 188 children	21
Second malignancy (SM) in prostate cancer patients treated with SBRT and other contemporary radiation techniques	21
MO-0725 Radiomics-based prediction of radiosensitivity from preclinical HNSCC histopathology imageS	21
PO-1964 Towards a novel treatment plan evaluation concept in carbon ion radiotherapy based on high-LET-dose	20
PO-1350 Quality of life changes in esophageal cancer patients treated with preoperative or Radical ChemoRT	20
PD-0418 Interstitial And Surface Mold Brachytherapy For Head And Neck Cancers- An Institutional Experience	20
PO-1344 Prognostic significance of platelet-to-lymphocyte ratio in hepatocellular carcinoma	20
MO-0148 Time trends for online adapative treatment on the 1.5T MR-Linac	20
PO-2225 Characterization of the RBE of various photon radiation qualities on human cancer cell lines	20
PO-2282 SABR Prostate: A review of specialised techniques for motion management	20
PO-2166 Commissioning of new rectal applicator using electronic brachytherapy source	20
OC-0437 Mature outcomes for TROG 99.03: RCT of RT +/- (R)-CVP in Stage I-II Follicular Lymphoma	20
PO-1386 Treatment outcomes of 1.5 T MR-guided adaptive radiotherapy for locally advanced pancreatic cancer	20
OC-0449 Deep learning based NTCP-modelling using 3D-information for predicting late xerostomia	20
SP-0016 Dopamine receptor antagonists, radiation, and cholesterol biosynthesis in mouse models of glioblastoma	20
OC-0436 A Delphi consensus study on SBRT for oligometastatic renal cell carcinoma (RCC) an ESTRO ACROP study	19
PO-1281 External validation of the MSKCC nomogram for Ductal Carcinoma in Situ and risk factors analysis	19
OC-0122 Deep Learning Segmentation of Cardiac Substructures in Radiotherapy Planning	19
PO-2038 Analysis of daily treatment fractions using PerFRACTION on a Halcyon linac	19
MO-0481 Towards near real-time adaptive proton therapy: the partial adaptation strategy	19
SP-1017 Proton arc therapy: Rationale and current status	19
PO-1694 MRI derived brain morphometric measurements: effect of voxel size, anisotropy and slice orientation	19
SP-1034 Oligometastatic renal cell carcinoma	19
OC-0592 Patient reported quality of life during and after primary radiotherapy for prostate cancer	19
PD-0805 Inter-observer variation for national Danish contouring atlas on organs at risk in the pelvis	19
OC-0466 Verification of rectal cancer target auto-contouring by trained RTTs in online adaptive MRIgRT	19
MO-0881 Evaluation of plan-of-the-day selection in adaptive radiation therapy of cervical cancer	19
PO-2130 clinical outcomes of brachytherapy combined with applicator-guided IMRT in bulky cervical tumor	18
OC-0254 Feasibility of RTT-only Conebeam CT-guided online adaptive radiotherapy for bladder cancer	18
33 Efficacy of Ultra Hypofrationed Radiotherapy Combined with HDR Brachytherapy	18
OC-0119 Interactive deep-learning for tumour segmentation in head and neck cancer radiotherapy	18
PO-1193 Pattern of practice in elderly patients with HPV positive oropharyngeal cancer: a multicenter study	18
PO-2245 In situ abscopal effect: synergistic efficacy of immunotherapy and partial tumor irradiation	18
PD-0248 Can surface imaging predict the impact of anatomical deformations on proton breast treatment?	18
MO-0390 Evaluating intra-breath-hold variation in IMAT breast boost patients delivered in DIBH	18
MO-0951 Outcome of total body irradiation for hematopoietic stem cell transplantation conditioning	18
206 Sharing Mono-Institutional Experience of Treating Pancreatic Cancer with Stereotactic Body Radiation Therapy (SBRT) as an Adjuvant Therapy for Non-Operative Patients or Salvaging Local Failure	18
126 Investigation of a Monte Carlo Model Based Dose Calculation for 103Pd Low Dose Rate Breast Brachytherapy	18
OC-0933 Automatically Triggered Surface-Based RT in DIBH in Breast Cancer - SAVE HEART dosimetry report	18
The long-term impact of irradiation on functional connectivity in brain circuits involved in memory processes after pediatric posterior fossa tumor	18
PD-0250 Intrafraction tumor motion monitoring and dose reconstruction for liver spot scanning proton therapy	18
PD-0398 Clinical outcomes of Thyroid Sparing Radical Chemoradiation in the treatment of Head and Neck cancer	18
PD-0401 The effect of dose to the brain on early self-reported neurocognition; does low dose matter?	18
PO-1131 Proton and carbon ion therapy for intracranial meningioma after previous brain radiotherapy	18
261 A 3D Star Shot to Determine Axes of Rotation	18
247 the Effect of CT Acquisition Parameters on Extracted Radiomic Features Using Computational Phantoms	18
OC-0942 Geometric stability during Stereotactic Arrhythmia Radiotherapy	18
PD-0962 Second PFS after post-PACIFIC relapse in the Blue Sky observational study on stage 3 NSCLC.	18
PD-0253 Ultra-compact and highly efficient proton therapy: Design considerations and clinical simulations	17
Intratumor genetic heterogeneity and head and neck cancer relapse	17
Response to comment on “Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC”	17
PD-0663 Deep learning cycleGAN MRI-only synthetic-CT generation for pelvis, brain and head and neck cancers	17
Further Data to Support Clinical Integration of Nodal Hypofractionation: A Commentary on the FAST-Forward Nodal Sub-study	17
PO-1530 Dosimetric comparison of Intraoperative Radiotherapy and SRS for liver metastases	17
Need for standardization in the use of structures in the intensity-modulated radiation therapy planning of head and neck cancers, a GORTEC study	17
OC-0428 Development of DNA polymerase theta inhibitors as tumour specific radiosensitisers	17
133: Interventions to Support Nutrition in Patients Undergoing Concurrent Chemoradiation for Esophageal Cancer: A Systematic Review of Randomized Trials	17
SP-0356 Low dose radiotherapy reverses resistance to immunotherapy: From bench to bedside	17
CNG (Collaborative Nasopharyngeal Carcinoma Group) stage: Improved prognostic stratification of nasopharyngeal carcinoma and association with Epstein-Barr virus DNA in the intensity-modulated radiatio	17
Contents	17
Moderate adverse events and regional differences in CDK4/6 inhibitor treatment combined with palliative radiotherapy	17
SP-0336 Spatially-fractionated radiotherapy: Tumour-subvolumes, dose-delivery and clinical applications	17
PO-1247 Safety of CDKI combined with radiotherapy in hormone receptor positive breast cancer	17
PO-1532 Long-term outcomes of proton beam therapy for elderly patients with prostate cancer	17
179 Contralateral Neck Recurrence Following Unilateral Treatment for Oral Tongue Squamous Cell Carcinoma	17
Comprehensive summary and retrospective evaluation of prognostic scores for patients with newly diagnosed brain metastases treated with upfront radiosurgery in a modern patient collective	16
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions	16
Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy group	16
Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial	16
161 14-day Pathway from Decision to Treat to Radiotherapy for Head and Neck Cancer in the National Health Service: An Evaluation of Feasibility and Outcomes at Torbay Hospital.	16
Severity of internal lymphedema in unilateral or bilateral radiotherapy patients: An exploratory study	16
Radiation therapy for stage IIA/IIB seminomas: Back to the future?	16
323: A comparison of 3D CNN architectures for monitoring ovarian cancer patients using PET/CT scans	16
OUTCOMES OF BRAIN METASTASIS FROM NON-SEMINOMATOUS GERM CELL TUMOUR: A POPULATION-BASED REVIEW	16
GETTING A HEAD START: REDUCING POST OPERATIVE RADIATION WAIT TIMES IN HEAD AND NECK CANCER	16
Dosimetric analysis of hearing loss after cranial radiation therapy in children: A single-institution study from the French national registry PediaRT	16
123 Can machine-learning model predict overall survival in head and neck cancer patients?	16
78 Targeting tumor-promoting myeloid cell functions in head & neck cancer	16
Prospective evaluation of in vivo and phantom repeatability and reproducibility of diffusion-weighted MRI sequences on 1.5 T MRI-linear accelerator (MR-Linac) and MR simulator devices for head and nec	16
Balancing robustness and adaptation rate for proton therapy of lung cancer patients	16
OFF-PROTOCOL RADIOTHERAPY IN PROSPECTIVE SYSTEMIC THERAPY TRIALS FOR METASTATIC NON-SMALL CELL LUNG CANCER	16
Caffeic Acid Phenethyl Ester (CAPE), a natural polyphenol to increase the therapeutic window for lung adenocarcinomas	16
The effect of delayed primary treatment initiation on adverse events and recurrence in older head and neck cancer patients	16
95 Head and neck cancers with synchronous primary cancers in Ireland	16
Fisetin overcomes non-targetability of mutated KRAS induced YB-1 signaling in colorectal cancer cells and improves radiosensitivity by blocking repair of radiation-induced DNA double-strand breaks	16
Treatment-related pulmonary adverse events induced by chemoradiation and Durvalumab affect survival in locally advanced non-small cell lung cancer	16